Your browser doesn't support javascript.
loading
The S. mansoni glycoprotein ω-1 induces Foxp3 expression in NOD mouse CD4⁺ T cells.
Zaccone, Paola; Burton, Oliver T; Gibbs, Sarah E; Miller, Nigel; Jones, Frances M; Schramm, Gabriele; Haas, Helmut; Doenhoff, Michael J; Dunne, David W; Cooke, Anne.
Afiliação
  • Zaccone P; Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, UK. pz206@cam.ac.uk
Eur J Immunol ; 41(9): 2709-18, 2011 Sep.
Article em En | MEDLINE | ID: mdl-21710488
ABSTRACT
Immunization with Schistosoma mansoni soluble antigen preparations protects non-obese diabetic (NOD) mice against the development of type 1 diabetes. These preparations have long been known to induce Th2 responses in vitro and in vivo. Recently, two separate groups have reported that ω-1, a well-characterized glycoprotein in S. mansoni soluble egg antigens (SEA), which with IL-4 inducing principle of S. mansoni eggs (IPSE/α-1) is one of the two major glycoproteins secreted by live eggs, is a major SEA component responsible for this effect. We found that ω-1 induces Foxp3 as well as IL-4 expression when injected in vivo. We confirmed that ω-1 conditions DCs to drive Th2 responses and further demonstrated that ω-1 induces Foxp3(+) T cells from NOD mouse naïve T cells. In contrast, IPSE/α-1 did not drive Foxp3 responses. The in vitro development of Foxp3-expressing T cells by ω-1 was TGF-ß- and retinoic acid-dependent. Our work, therefore, identifies ω-1 as an important factor for the induction of Foxp3(+) T cells by SEA in NOD mice.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Schistosoma mansoni / Linfócitos T CD4-Positivos / Interleucina-4 / Diabetes Mellitus Tipo 1 / Fatores de Transcrição Forkhead Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Eur J Immunol Ano de publicação: 2011 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Schistosoma mansoni / Linfócitos T CD4-Positivos / Interleucina-4 / Diabetes Mellitus Tipo 1 / Fatores de Transcrição Forkhead Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Eur J Immunol Ano de publicação: 2011 Tipo de documento: Article País de afiliação: Reino Unido